ABSTRACT
Background:Respiratory infection is a disease which the incidence and mortality rank highest among children diseases under 5 years old. The reasons caused respiratory infection are virus, bacterium and parasite. H.Influenzae, St.pneumoniae and M.Cataralis are the main reason leading to respiratory infection. Objectives:This study aims to research on the efficacy of Bronchovaxom in reducing the rate of acute respiratory infection in children. Subjects and method:A descriptive, prospective and cohort study was conducted on 60 patients was used Bronchovaxom for two times with the 6 months of interval in the National Hospital for Pediatric from January 2006 to September 2007. Results:Among the first selection 60 children, 15 children stopped to participate in the study. The age ranged from 32 months to 88 months, the mean age was 55.4 months. Male was 30 (66.7%); female was 15 ( 33.3%). 100% were injected vaccination. There was a clear reduction in the incidence. The frequency of antibiotic use was also reduced. In particular, increased level of IgA in the patient's saliva following treatment with Bronchovaxom. Conclusion:There was a significantly statistical difference on the times of acute recurrentrespiratory infection in one year on the same patient before and after using Bronchovaxom.